Expertise in
8
conditions

Dr. Helene A. Emsellem

Sleep Medicine
The George Washington University Hospital
901 23rd St NW, 
Washington, DC 
Expertise in
8
conditions
The George Washington University Hospital
901 23rd St NW, 
Washington, DC 

Overview

Helene Emsellem is a Sleep Medicine provider practicing medicine in Washington, Washington, D.c..

Dr. Emsellem is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Drowsiness, Narcolepsy, Excessive Daytime Sleepiness, and Obstructive Sleep Apnea.

She is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 16 clinical trials.

Specialties

Sleep Medicine

Licenses

Psychiatry & Neurology in MD

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

The George Washington University Hospital
901 23rd St NW, Washington, DC 20037

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: August 12, 2026
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
Double-Blind, Placebo-Controlled, Dose-Range-Finding, Crossover Trial of Single Day Administration of ERX-963 in Adults With Myotonic Dystrophy Type 1
Double-Blind, Placebo-Controlled, Dose-Range-Finding, Crossover Trial of Single Day Administration of ERX-963 in Adults With Myotonic Dystrophy Type 1
Enrollment Status: Completed
Publish Date: June 23, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 9 Less Clinical Trials

21 Total Publications

Fatigue is distinct from sleepiness and negatively impacts individuals living with obstructive sleep apnea (OSA): results from qualitative research of individuals with OSA.
Fatigue is distinct from sleepiness and negatively impacts individuals living with obstructive sleep apnea (OSA): results from qualitative research of individuals with OSA.
Journal: Health and quality of life outcomes
Published: August 31, 2024
Similar Doctors
Expertise in
6
conditions
Dr. Peter L. Whitesell
Sleep Medicine
Expertise in
6
conditions
Dr. Peter L. Whitesell
Sleep Medicine
Referral may be required

Hu Faculty Practice Plan-Sleep Center

2041 Georgia Ave NW, 
Washington, DC 
 (2.0 miles away)
202-865-2122
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Peter Whitesell is a Sleep Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Whitesell is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Insomnia, Irregular Sleep-Wake Syndrome, and Central Sleep Apnea.

Expertise in
5
conditions
Dr. Zara Martirosyan
Sleep Medicine
Expertise in
5
conditions
Dr. Zara Martirosyan
Sleep Medicine
Referral may be required

Hu Faculty Practice Plan-Sleep Center

2041 Georgia Ave NW, 
Washington, DC 
 (2.0 miles away)
202-865-2122
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Zara Martirosyan is a Sleep Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Martirosyan is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Irregular Sleep-Wake Syndrome, Drowsiness, Excessive Daytime Sleepiness, and Posterior Fossa Decompression.

Expertise in
3
conditions
Dr. Marc F. Schlosberg
Sleep Medicine
Expertise in
3
conditions
Dr. Marc F. Schlosberg
Sleep Medicine
Referral may be required

Office

106 Irving St NW Ste 421, 
Washington, DC 
 (2.5 miles away)
202-877-5119
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Marc Schlosberg is a Sleep Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Schlosberg is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, REM Behavior Disorder, Narcolepsy, and Irregular Sleep-Wake Syndrome.

Expertise in
4
conditions
Dr. Kalpana M. Hari
Sleep Medicine
Expertise in
4
conditions
Dr. Kalpana M. Hari
Sleep Medicine
Referral may be required

Kathi Kolbe MSW LLC

5454 Wisconsin Ave, 
Chevy Chase, MD 
 (4.7 miles away)
301-562-7200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kalpana Hari is a Sleep Medicine provider practicing medicine in Chevy Chase, Maryland. Dr. Hari is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, and Narcolepsy. Dr. Hari is currently accepting new patients.

Expertise in
1
conditions
Dr. Lynn Kataria
Sleep Medicine
Expertise in
1
conditions
Dr. Lynn Kataria
Sleep Medicine
Referral may be required

VA Medical Center

50 Irving St NW, 
Washington, DC 
 (3.0 miles away)
202-745-8145
Languages Spoken:
English

Lynn Kataria is a Sleep Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Kataria is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea and Traumatic Brain Injury.

Expertise in
3
conditions
Dr. Hiral J. Padia
Sleep Medicine
Expertise in
3
conditions
Dr. Hiral J. Padia
Sleep Medicine
Referral may be required

Comprehensive Sleep Care Center Inc

200 N Glebe Rd, 
Arlington, VA 
 (3.5 miles away)
703-729-3420
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hiral Padia is a Sleep Medicine provider practicing medicine in Arlington, Virginia. Dr. Padia is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Insomnia, Restless Legs Syndrome, and Irregular Sleep-Wake Syndrome. Dr. Padia is currently accepting new patients.

Frequently Asked Questions about Dr. Helene A. Emsellem

How do I make an appointment with Dr. Helene A. Emsellem?

You can book an appointment with Dr. Helene A. Emsellem by calling their office at 202-994-3291. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Helene A. Emsellem a top-rated expert for Drowsiness?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Helene A. Emsellem is classified as an Elite expert for Drowsiness, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Helene A. Emsellem specialize in?

While Dr. Helene A. Emsellem is a Sleep Medicine, they have specific expertise in Drowsiness, Narcolepsy, and Excessive Daytime Sleepiness. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Helene A. Emsellem participate in research or clinical trials?

Yes. Dr. Helene A. Emsellem has published 21 articles and abstracts on conditions like Drowsiness. You can view a list of Dr. Helene A. Emsellem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Helene A. Emsellem accept my insurance?

Dr. Helene A. Emsellem accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-994-3291 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Emsellem's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile